LEADER 01893nam 2200433 450 001 9910466814203321 005 20200120100955.0 010 $a2-335-01224-X 035 $a(CKB)3790000000023287 035 $a(EBL)2086440 035 $a(MiAaPQ)EBC2086440 035 $a(Au-PeEL)EBL2086440 035 $a(OCoLC)914153018 035 $a(EXLCZ)993790000000023287 100 $a20200120d2014 uy d 101 0 $afre 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 12$aL'amour me?decin /$fMolie?re 210 1$a[Place of publication not identified] :$cLigaran,$d[2014] 210 4$dİ2014 215 $a1 online resource (84 p.) 300 $aDescription based upon print version of record. 327 $aCouverture; Page de Copyright; Page de titre; Au lecteur; Personnages; Prologue; Acte premier; Sce?ne I; Sce?ne II; Sce?ne III; Sce?ne IV; Sce?ne V; Sce?ne VI; Sce?ne VII; Sce?ne VIII; Sce?ne IX; Acte deuxie?me; Sce?ne I; Sce?ne II; Sce?ne III; Sce?ne IV; Sce?ne V; Sce?ne VI; Sce?ne VII; Sce?ne VIII; Acte troisie?me; Sce?ne I; Sce?ne II; Sce?ne III; Sce?ne IV; Sce?ne V; Sce?ne VI; Sce?ne VII; Sce?ne VIII; Sce?ne IX 330 $aExtrait : ""LISETTE : Que voulez-vous donc faire, Monsieur, de quatre me?decins ? N'est-ce pas assez d'un pour tuer une personne ? SGANARELLE : Taisez-vous. Quatre conseils valent mieux qu'un. LISETTE : Est-ce que votre fille ne peut pas bien mourir, sans le secours de ces messieurs-la? ? "" 606 $aFrench drama 608 $aElectronic books. 615 0$aFrench drama. 676 $a822 700 $aMolie?re$f1622-1673,$0389055 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910466814203321 996 $aL'amour me?decin$92001716 997 $aUNINA LEADER 03191oam 2200481I 450 001 9910163101503321 005 20240505182026.0 010 $a1-315-36495-6 010 $a1-315-34130-1 010 $a981-4463-16-7 024 7 $a10.1201/9781315364957 035 $a(CKB)2670000000394385 035 $a(MiAaPQ)EBC4779014 035 $a(OCoLC)967412278 035 $a(PPN)224786032 035 $a(BIP)61409847 035 $a(BIP)50652094 035 $a(EXLCZ)992670000000394385 100 $a20180331h20172017 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aNanoparticles in humans $eexperiments, methods, and strategies /$fLev S. Ruzer 205 $a1st ed. 210 1$aSingapore :$cPan Stanford Publishing Pte. Ltd.,$d[2017] 210 4$dİ2017 215 $a1 online resource (127 pages) 300 $aIncludes index. 311 08$a981-4463-17-5 327 $a1. Radon deadlock -- 2. Measurement of the concentration of decay products of radon, thoron, and actinon -- 3. Unattached activity of radon progeny -- 4. Method of direct measurement of activity (dose) in miners' lungs -- 5. Assessment of the nanoparticles' surface area by measuring the unattached activity of radon progeny -- 6. Local deposition of nanoparticles in the human lung -- 7. Exposure and dose in nanoaerosols studies. 330 $aA peek into the literature on the environmental health implications of the rapidly developing nanotechnology industry shows that the potential problem of exposure to airborne nanoparticles has not been adequately addressed. The health and safety of nanotechnology workers are of concern because these groups run the greatest risk of exposure to elevated concentrations of nanomaterials. However, a gap exists between the currently available particle measurement methods and those appropriate for the assessment of nanoaerosol exposure. This book presents new ideas and methods to measure the surface area and local deposition of nanoparticles in the lungs and the true value of respirators. It proposes a nanoparticle dosimetric road map that can be used as a general strategy for the assessment of the dose, which is the most important physical cause of adverse effects on health in the case of nanoparticle exposure. The book suggests the use of 1 nm radioactive particles, called unattached activity of radon progeny, as a safe experimental tool for nanoparticle studies, including human studies. It discusses the problems related to the general strategy of risk assessment in nanoparticle exposure and concrete parameters related to dosage. The ideas presented in this book help close the gaps in our knowledge of aerosols in the nanometer range and improve our understanding of nanoparticle behavior in the air and in the human body. 606 $aNanoparticles$xAnalysis 615 0$aNanoparticles$xAnalysis. 676 $a620.5 700 $aRuzer$b Lev S$g(Lev Solomonovich),$0972340 801 0$bFlBoTFG 801 1$bFlBoTFG 906 $aBOOK 912 $a9910163101503321 996 $aNanoparticles in humans$92210868 997 $aUNINA